Jay Cullen
Directeur/Membre du Conseil chez Evozym Biologics, Inc.
Provenance du réseau au premier degré de Jay Cullen
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
Evozym Biologics, Inc.
 Evozym Biologics, Inc. Miscellaneous Commercial ServicesCommercial Services Evozym Biologics, Inc. develops a technology platform that utilizes evolutionary biology to transform gene profiles into novel proteins. The private company is based in Lewes, DE. The company was founded by Joseph Grzymski. Joseph Grzymski has been the CEO since incorporation.
2
| Private Company | Miscellaneous Commercial Services | 2 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Jay Cullen via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
Bowdoin College
 Bowdoin College Other Consumer ServicesConsumer Services Bowdoin College is an independent, nonsectarian, coeducational residential, undergraduate liberal arts institution founded in 1794. It is located in Brunswick, ME. | College/University | Undergraduate Degree Undergraduate Degree | |
| Rutgers State University of New Jersey | College/University | Doctorate Degree | |
Gemvax AS
 Gemvax AS Pharmaceuticals: MajorHealth Technology Part of GemVax & KAEL Co., Ltd., Gemvax AS is a Norwegian peptide-based drug development company that focuses on researching and developing treatments for Alzheimer's disease and prostate hyperplasia. The company is based in Porsgrunn, Norway. The company also develops and sell products such as CA filters and provide investment information. The company was founded by Mona Elisabeth Møller. Gemvax was acquired by VaxOnco, Inc. from Pharmexa A/S on October 30, 2008. | Pharmaceuticals: Major | Director/Board Member | |
| Pharmexa, Inc. | Chief Executive Officer | ||
Multimeric Biotherapeutics, Inc.
 Multimeric Biotherapeutics, Inc. BiotechnologyHealth Technology Multimeric Biotherapeutics, Inc. operates as a early-stage biotech company. Its products include clinical pipeline MagaVax vaccines, tumor immunotherapy, ovarian cancer immunotherapy, MegaLigands, and UltraLigands. The company was founded in 2008 and is headquartered in La Jolla, CA. | Biotechnology | Chairman | |
| GRI BIO, INC. | Biotechnology | Chief Executive Officer | |
GRI Operations, Inc.
 GRI Operations, Inc. BiotechnologyHealth Technology GRI Bio, Inc. develops cell based therapies for fibrotic and autoimmune diseases. Its programs are GRI-0621, GRI-0124, and GRI-0803. The company was founded by Marc Hertz, Vipin Kumar, and Albert Agro and is headquartered in La Jolla, CA. | Biotechnology | Founder |
Statistiques
Internationale
| Etats-Unis | 8 |
| Norvège | 2 |
Sectorielle
| Health Technology | 6 |
| Consumer Services | 3 |
Opérationnelle
| Director/Board Member | 5 |
| Chief Executive Officer | 5 |
| President | 3 |
| Chairman | 2 |
| Undergraduate Degree | 2 |
Relations les plus connectées
| Insiders | |
|---|---|
| W. Hertz | 8 |
| Joseph Grzymski | 3 |
- Bourse
- Insiders
- Jay Cullen
- Connexions Sociétés
